About Pharmanel Pharmaceuticals
Pharmanel Pharmaceuticals was established in 1991 and is based in Gerakas, Greece. Operations are centered on the pharmaceutical sector, with generic drugs produced as the primary focus. Manufacturing processes are conducted to supply affordable alternatives to branded medications. Distribution occurs mainly within Greece, supported by the domain pharmanel.gr for operational and informational purposes. The company maintains a presence in the generics market without emphasis on branded innovations.
- Headquarter Gerakas, Greece
- SectorsHealthcare
- Website pharmanel.gr
- Social LinkedIn
- Acquired by Vianex (Jul 2019)
- Legal Name Pharmanel A.E.
Investors in Pharmanel Pharmaceuticals
Pharmanel Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Vianex.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Vianex is engaged in the production of pharmaceutical products. | – | vianex.gr | Greece |
Investor details for Pharmanel Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Pharmanel Pharmaceuticals
2 dated milestones of Pharmanel Pharmaceuticals across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Pharmanel Pharmaceuticals is founded.
- Exit Acquired by Vianex.
Similar companies to Pharmanel Pharmaceuticals
10 companies that operate in the same segment as Pharmanel Pharmaceuticals (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pharmanel Pharmaceuticals
Pharmanel Pharmaceuticals was founded in 1991.
Pharmanel Pharmaceuticals is headquartered in Gerakas, Greece. It is registered at Gerakas, Attica, Greece.
Pharmanel Pharmaceuticals was established in 1991 and is based in Gerakas, Greece. Operations are centered on the pharmaceutical sector, with generic drugs produced as the primary focus. Manufacturing processes are conducted to supply affordable alternatives to branded medications. Distribution occurs mainly within Greece, supported by the domain pharmanel.gr for operational and informational purposes. The company maintains a presence in the generics market without emphasis on branded innovations.
Pharmanel Pharmaceuticals has 1 investor. Key investors include Vianex.
Pharmanel Pharmaceuticals operates through Pharmanel A.E..
Yes. Pharmanel Pharmaceuticals was acquired by Vianex in July 2019.